Have a question or need more info? Fill out the form and we'll get back to you soon.
Aerobe provides cutting-edge technology and scientific expertise to support researchers and clinicians in their endeavors to find innovative solutions in a range of disciplines.
.png)
.png)
The hospital's primary focus is the care of children with severe burn injuries.
.png)
Is your beard not growing as full as you'd like? Are you plagued by small gaps or bald patches? A beard roller promises relief.
.png)
In this one-day workshop, we will target topics of the integration between humans and machines/devices through cognitive and physiological monitoring during daily living, and we will discuss the implications of this integration, methods and hands-on experiments.
.png)
An interdisciplinary two-day conference in Cambridge with a wide-range of workshops, tutorials, keynotes and latest research posters & presentations sessions for the community of researchers and practitioners in functional near-infrared spectroscopy (fNIRS) based in the UK and neighbouring regions.
.png)
A new version of EGZOClinic is available! We just got released a new version: v.1.5.0. and it can be installed on your Sidra LEG / Meissa OT / Stella BIO via regular updating procedure.
.png)
To update the software, connect the device to the Internet and click on the notification regarding the new software version. The application will guide you through the update process.
.png)
EGZOTech is dedicated for designing and manufacturing advanced rehabilitation robots. Our passion for cutting-edge technology and commitment to improving people’s lives resulted in being a leader in the sector of robotic aided rehabilitation.
.png)
Approximately 30% of U.S. adolescents diagnosed with major depressive disorder (MDD) do not respond to standard treatments and meet criteria for treatment-resistant depression (TRD). Transcranial Magnetic Stimulation (TMS) is considered a safe and effective treatment option for adolescents with Major Depressive Disorder.
.png)
The system is now indicated as an adjunct treatment for Major Depressive Disorder (MDD) in adolescent patients aged 15 to 21 who have not responded adequately to prior antidepressant medication.
© 2025 Aerobe.
All rights reserved.
